P
Privia Health Group, Inc. (PRVA)
NMS – Real Time Price. Currency in USD
23.01
+0.25 (1.10%)
At close: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
23.01
+0.25 (1.10%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.61 | 2.19 | 8.0 | |
| Quick ratio | 1.61 | 1.96 | 8.0 | |
| Debt to Equity | 0.01 | 1.16 | 9.0 | |
| Debt to Assets | 0.01 | 2.94 | 10 | |
| Interest coverage | N/A | -28.30 | 10 | |
| Weighted average score | 9.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 1.36B | 1.66B | 1.74B | 2.12B | 2.25B |
| Gross Profit | 130M | 155M | 170M | 200M | 213M |
| Operating Income | -19M | 21M | 17M | 34M | 36M |
| Net Income | -9M | 23M | 14M | 23M | 22M |
| EBITDA | -15M | 27M | 24M | 44M | 48M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 14.08 | 249.02 | 9.0 |
| Next quarter | 6.29 | 74.03 | 7.5 |
| Current year | 13.5 | 48.51 | 9.0 |
| Next year | 10.23 | 54.42 | 8.5 |
| Weighted average score | 8.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 11.58 | -66.51 | -71.42 | -138.81 | 2.5 |
| Y/Y | 25.78 | -27.38 | -33.32 | -105.68 | 3.3 |
| 3y average | 16.4 | 130.17 | 119.68 | 52.04 | 9.8 |
| 5y average | 21.57 | -43.29 | -41.37 | 36.81 | 5.5 |
| Weighted average score | 5.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $419.5M significantly exceed its total debt $9.0M, ensuring strong financial flexibility
Total current assets $966.0M exceed Total current liabilities $601.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (1.2), showcasing prudent financial management
The company has no interest-bearing debt, showcasing excellent financial strength
Negative free cash flow -$49.5M limits the company's ability to reinvest or pay down debt